Furthermore, we found a significant increase in the levels of CD33+CD11b+HLA-DR−/lowCD14−CD15− cells identified as IM-MDSC in tumor tissue (NT; 0.5 ± 0.2 vs TT; 7.8 ± 3.5). The gene discussed is CD33; the disease is neoplasm.